Aardvark Therapeutics (AARD) Current Leases (2024 - 2026)
Aardvark Therapeutics (AARD) reported Current Leases of $336000.0 for Q1 2026, down 13.85% on a YoY basis from $390000.0 in Q1 2025, and down 23.81% sequentially from $441000.0 in Q4 2025.
Aardvark Therapeutics (AARD) Current Leases (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Current Leases data on file, last reported at $336000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 13.85% year-over-year to $336000.0; the trailing twelve-month figure through Mar 2026 stood at $336000.0 (down 13.85% YoY), and the FY2025 full-year result was $441000.0, up 30.47% from the prior year.
- Current Leases fell to $336000.0 in Q1 2026, from $441000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $441000.0 in Q4 2025 to a low of $336000.0 in Q1 2026.
- A 3-year average of $391833.3 and a median of $403500.0 in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases soared 30.47% in 2025 and decreased 13.85% in 2026, its largest moves.
- Tracing AARD's Current Leases over 3 years: stood at $338000.0 in 2024, then surged by 30.47% to $441000.0 in 2025, then retreated by 23.81% to $336000.0 in 2026.
- Business Quant data shows AARD's Current Leases at $336000.0 in Q1 2026, $441000.0 in Q4 2025, and $429000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | 336,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 336,000.00 |
| Dec 31, 2025 | 441,000.00 |
| Sep 30, 2025 | 429,000.00 |
| Jun 30, 2025 | 417,000.00 |
| Mar 31, 2025 | 390,000.00 |
| Dec 31, 2024 | 338,000.00 |